Organization
Biocon Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Biocon Ltd.
... 'Biocon has received the EU GMP certification for its Sterile Drug Product manufacturing ...
... be sent to Email: Tel: 080 2808 2808 Ms. Seema Ahuja Contact: Biocon clarifies that it retains its economic interest in this arrangement vis-A -vis ...
... Biocon Ltd, Asia's premier biopharmaceutical company, announced today that its Chairperson and Managing ...
... 'The Company confirms that Biocon has received an Establishment Inspection Report (EIR) from the USFDA for its ...
... Mylan N.V.(NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that 48-week results from ...
... Biocon Ltd, Asia's premier biopharmaceutical company, announced today that its Chairperson and Managing ...
... priority for product development among leading players in the market. For instance, Biocon is engaged in the clinical trials of oncology biosimilars such as Trastuzumab ...
... Mylan and Biocon have agreed to accelerate introduction of adalimumab biosimilar in Europe through Mylan's ...
... Mylan N.V. (NASDAQ: MYL), one of the world's leading pharmaceutical companies, and Biocon Ltd. (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceutical company, today announced ...
... 'Biocon had issued a statement to the stock exchanges on Feb 21, 2018, ...
Subscribe now for full coverage on Biocon Ltd.
Start My Free Trial